The proposed Emory University Alzheimer's Disease Research Center (ADC) will serve as a shared resource to facilitate and enhance interdisciplinary research in Alzheimer's disease (AD) and related disorders. The Emory ADC offers a broad range of expertise in basic and clinical research that will allow exploration of all aspects of AD and related disorders. The Education/Information Transfer Core (Education Core) of the ADC will provide educational programs and materials on AD to the community, families, health care professionals, and students. The major aims of the Core are to 1) Expand the infrastructure for educational activities to support scientific inquiry related to AD disease and related disorders through recruitment and retention of study participants with a special emphasis on under-represented groups; 2) Improve recognition of MCI, early AD and related disorders and emphasize the importance of autopsy through community education for families, caregivers, community lay leaders and health care professionals with a special focus on the African American community; 3) Augment interdisciplinary linkages and collaborative research to enhance and facilitate the study of AD through shared clinical, theoretical, and methodological perspectives and resources at all educational and practice levels . The Education Core will achieve these aims in a number of ways such as insuring cultural sensitivity in educational materials and presentations; creating a Community Advisory Board for guidance in reaching under-represented groups; developing cultural competence among ADC staff; innovative programs for recruitment activities; and using existing and new community and professional partners such as other Cores and ADCs, geriatric groups on campus, the Alzheimer's Association, Area Health Education Centers, and the Atlanta Regional Commission. Educational programs will be carefully evaluated using specific outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
1P50AG025688-01
Application #
6933613
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J4))
Project Start
2005-04-01
Project End
2010-03-31
Budget Start
2005-04-01
Budget End
2006-04-30
Support Year
1
Fiscal Year
2005
Total Cost
$67,332
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Rangaraju, Srikant; Raza, Syed Ali; Li, Noel Xiang'An et al. (2018) Differential Phagocytic Properties of CD45low Microglia and CD45high Brain Mononuclear Phagocytes-Activation and Age-Related Effects. Front Immunol 9:405
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Chalermpalanupap, Termpanit; Schroeder, Jason P; Rorabaugh, Jacki M et al. (2018) Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice. J Neurosci 38:74-92
Maezawa, Izumi; Nguyen, Hai M; Di Lucente, Jacopo et al. (2018) Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept. Brain 141:596-612
Bishof, Isaac; Dammer, Eric B; Duong, Duc M et al. (2018) RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease. J Biol Chem 293:11047-11066
Peng, Katherine Y; Pérez-González, Rocío; Alldred, Melissa J et al. (2018) Apolipoprotein E4 genotype compromises brain exosome production. Brain :
Gangishetti, Umesh; Christina Howell, J; Perrin, Richard J et al. (2018) Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimers Res Ther 10:98
Zhang, Qi; Ma, Cheng; Gearing, Marla et al. (2018) Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease. Acta Neuropathol Commun 6:19
Umoh, Mfon E; Dammer, Eric B; Dai, Jingting et al. (2018) A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med 10:48-62
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169

Showing the most recent 10 out of 444 publications